Phanes Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$40M
- Investors
-
7
Phanes Therapeutics General Information
Description
Operator of a biotechnology company intended to focus on drug discovery and early development in immuno-oncology. The company develops native Immunoglobulin G-like bispecific antibodies that enhance drug-like properties to a cure, enabling patients to access new drugs more efficiently.
Contact Information
Website
www.phanesthera.comCorporate Office
- 11535 Sorrento Valley Road
- Suite 400
- San Diego, CA 92121
- United States
Corporate Office
- 11535 Sorrento Valley Road
- Suite 400
- San Diego, CA 92121
- United States
Phanes Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 06-May-2021 | $40M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | 01-Nov-2018 | Completed | Startup |
Phanes Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Phanes Therapeutics Comparisons
Industry
Financing
Details
Phanes Therapeutics Competitors (72)
One of Phanes Therapeutics’s 72 competitors is Kymera Therapeutics, a Formerly VC-backed company based in Watertown, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kymera Therapeutics | Formerly VC-backed | Watertown, MA | ||||
| Cantex Pharmaceuticals | Formerly VC-backed | Weston, FL | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Precigen | Formerly VC-backed | Germantown, MD | ||||
| Byondis | Corporation | Nijmegen, Netherlands |
Phanes Therapeutics Patents
Phanes Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025147472-A1 | Anti-611-ctf p95her2 antibodies and uses thereof | Inactive | 02-Jan-2024 | ||
| WO-2024182475-A2 | Anti-ror2 antibodies and uses thereof | Inactive | 02-Mar-2023 | ||
| WO-2024182475-A3 | Anti-ror2 antibodies and uses thereof | Inactive | 02-Mar-2023 | ||
| EP-4615501-A1 | Anti-5t4 antibodies and uses thereof | Pending | 08-Nov-2022 | ||
| US-20260167739-A1 | Anti-5t4 antibodies and uses thereof | Pending | 08-Nov-2022 | C07K16/30 |
Phanes Therapeutics Signals
Phanes Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Delos Capital Partners | Venture Capital | Minority | ||
| DYEE Capital | Asset Manager | Minority | ||
| HSG (Hong Kong) | Venture Capital | Minority | ||
| Sequoia Capital | Venture Capital | Minority | ||
| Volcanics Venture | Venture Capital | Minority |
Phanes Therapeutics FAQs
-
When was Phanes Therapeutics founded?
Phanes Therapeutics was founded in 2016.
-
Where is Phanes Therapeutics headquartered?
Phanes Therapeutics is headquartered in San Diego, CA.
-
What is the size of Phanes Therapeutics?
Phanes Therapeutics has 29 total employees.
-
What industry is Phanes Therapeutics in?
Phanes Therapeutics’s primary industry is Drug Discovery.
-
Is Phanes Therapeutics a private or public company?
Phanes Therapeutics is a Private company.
-
What is Phanes Therapeutics’s current revenue?
The current revenue for Phanes Therapeutics is .
-
How much funding has Phanes Therapeutics raised over time?
Phanes Therapeutics has raised $55M.
-
Who are Phanes Therapeutics’s investors?
Delos Capital Partners, DYEE Capital, HSG (Hong Kong), Sequoia Capital, and Volcanics Venture are 5 of 7 investors who have invested in Phanes Therapeutics.
-
Who are Phanes Therapeutics’s competitors?
Kymera Therapeutics, Cantex Pharmaceuticals, CytomX Therapeutics, Precigen, and Byondis are some of the 72 competitors of Phanes Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process